Cargando…
COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256555/ https://www.ncbi.nlm.nih.gov/pubmed/32473945 http://dx.doi.org/10.1016/j.bbi.2020.05.067 |
| _version_ | 1783539935960104960 |
|---|---|
| author | Mongan, David Cannon, Mary Cotter, David R. |
| author_facet | Mongan, David Cannon, Mary Cotter, David R. |
| author_sort | Mongan, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7256555 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72565552020-05-29 COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders Mongan, David Cannon, Mary Cotter, David R. Brain Behav Immun Article Elsevier Inc. 2020-08 2020-05-29 /pmc/articles/PMC7256555/ /pubmed/32473945 http://dx.doi.org/10.1016/j.bbi.2020.05.067 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Mongan, David Cannon, Mary Cotter, David R. COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders |
| title | COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders |
| title_full | COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders |
| title_fullStr | COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders |
| title_full_unstemmed | COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders |
| title_short | COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders |
| title_sort | covid-19, hypercoagulation and what it could mean for patients with psychotic disorders |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256555/ https://www.ncbi.nlm.nih.gov/pubmed/32473945 http://dx.doi.org/10.1016/j.bbi.2020.05.067 |
| work_keys_str_mv | AT mongandavid covid19hypercoagulationandwhatitcouldmeanforpatientswithpsychoticdisorders AT cannonmary covid19hypercoagulationandwhatitcouldmeanforpatientswithpsychoticdisorders AT cotterdavidr covid19hypercoagulationandwhatitcouldmeanforpatientswithpsychoticdisorders |